Shay Capital’s Endovia Health Sciences, Inc. EDVA Stock Holding History

Shay Capital’s Portfolio EDVA Stock Details EDVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-313	Closed	-$182K	–	678
2021 Q2	$182K	Buy	+313	New	+$171K	0.02%	423

Other funds holding EDVA

PCM

Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCA

Berman Capital Advisors Atlanta, Georgia $636M AUM 30.04% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Shay Capital's EDVA Position: Q3 2021 in Review

Shay Capital sold out of Endovia Health Sciences, Inc. (EDVA) in Q3 2021, closing a stake of 313 shares — an estimated $182K sold.

Shay Capital first reported a position in EDVA in Q2 2021 and held it in 1 quarter. The position peaked at $182K in Q2 2021. 13 funds tracked by Wall St. Rank hold EDVA as of Q3 2021.

Shay Capital reported no remaining Endovia Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Shay Capital sold 313 Endovia Health Sciences, Inc. shares in Q3 2021, an estimated $182K.
Shay Capital first reported a position in Endovia Health Sciences, Inc. in Q2 2021 and held it in 1 quarter.
Shay Capital's Endovia Health Sciences, Inc. position peaked at $182K in Q2 2021.
13 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q3 2021.

Based on Shay Capital's 13F filing for Q3 2021, filed 15 Nov 2021.